An observational study of once-daily modified-release methylphenidate in ADHD: quality of life, satisfaction with treatment and adherence

Attention deficit hyperactivity disorder (ADHD) impacts significantly on the quality of life (QoL) of patients and their families. Choice of therapy is increasingly influenced by treatment satisfaction and patient preference, with once-daily modified-release methylphenidate (MPH-MR) formulations off...

Descripción completa

Detalles Bibliográficos
Autores principales: Rothenberger, Aribert, Becker, Andreas, Breuer, Dieter, Döpfner, Manfred
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Supplement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180635/
https://www.ncbi.nlm.nih.gov/pubmed/21901416
http://dx.doi.org/10.1007/s00787-011-0203-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180635/
https://www.ncbi.nlm.nih.gov/pubmed/21901416
http://dx.doi.org/10.1007/s00787-011-0203-3

Ejemplares similares